
Ivadib 5mg Tablet
Marketer
Prevego Healthcare & Research Private Limited
Salt Composition
Ivabradine (5mg)
Overview Ivadib 5mg Tablet
Cardiol 5mg tablets treat angina pectoris (chest pain stemming from heart issues) and chronic congestive heart failure. It enhances cardiac function by reducing heart rate, easing chest discomfort, and lowering hospitalization risk in heart failure patients. Dosage varies based on the specific condition. Because treatment for these conditions is typically lifelong, discontinue use only after consulting your physician. Administer with food at the same time daily. Overdose may cause excessive bradycardia, breathlessness, and fatigue; seek immediate medical attention if this occurs. Common side effects include transient visual disturbances, bradycardia, hypertension, atrial fibrillation, vertigo, blurred vision, and electrocardiographic abnormalities. Serious side effects like syncope and significant arrhythmias require urgent medical care. Refrain from driving until the medication's effects are known. Avoid use in patients with severe hepatic impairment, bradycardia, arrhythmias, significantly low blood pressure, or recently exacerbated heart failure. Interactions may occur with certain antihypertensives, antifungals, and antiretrovirals. Contraindicated in pregnancy, pregnancy planning, and lactation.
Primary Ingredients of Ivadib 5mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Ivadib 5mg Tablet
Managing angina pectoris and heart failure.
Major Benefits of Ivadib 5mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 5mg Ivadib tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
Common Side effects of Ivadib 5mg Tablet:
- Slow heart rate
- Luminous phenomena (Enhanced brightness)
- High blood pressure
- Atrial fibrillation
- Dizziness
- Blurred vision
- ECG changes
How to use Ivadib 5mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Ivadib 5mg Tablet should be taken with a meal.
How Ivadib 5mg Tablet works:
CardioRate 5mg tablets decrease heart rate, thereby reducing the heart's oxygen demand and improving its overall efficiency.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Ivadib 5mg Tablet lacks established safety data. Seek medical advice before combining them.
PregnancyUNSAFE
Pregnant individuals should absolutely avoid Ivadib 5mg Tablets. Research in both animal and human pregnancy has revealed substantial risks to fetal development, necessitating consultation with a physician before use.
Breast feedingUNSAFE
Breastfeeding mothers should avoid Ivadib 5mg tablets. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Driving ability may be impaired by Ivadib 5mg Tablet, a medication that can induce transient visual disturbances, primarily phosphenes. Night driving, in particular, should be considered carefully given the potential for these light flashes.
KidneyCAUTION
Individuals with severe kidney impairment should exercise caution when using Ivadib 5mg tablets. Dosage modification may be necessary. A physician's consultation is recommended. Data regarding Ivadib 5mg tablet use in patients with severe kidney disease is limited.
LiverCAUTION
Patients with liver impairment should use Ivadib 5mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Ivadib 5mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Ivadib 5mg Tablet :
Omit any missed dose of Ivadib 5mg Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ivadib 5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzazepine compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Action Class | Sodium channel blockers targeting the sinoatrial node |
